1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
2.66%
Cash & equivalents growing 2.66% while CRON.TO's declined -1.07%. Peter Lynch would see this as a sign of superior liquidity management.
No Data
No Data available this quarter, please select a different quarter.
2.66%
Below half of CRON.TO's -1.71%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
0.05%
Receivables growth less than half of CRON.TO's 38.65%. David Dodd might see more conservative credit practices, provided revenue isn't suffering.
47.19%
Inventory growth above 1.5x CRON.TO's 5.91%. Michael Burry might suspect a looming inventory glut. Check free cash flow impact.
11.61%
Higher Other Current Assets Growth compared to CRON.TO's zero value, indicating worse performance.
10.71%
Below half of CRON.TO's -0.56%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
3.89%
Similar yoy growth to CRON.TO's 3.93%. Walter Schloss sees parallel capital spending strategies. Check utilization rates.
-0.80%
Above 1.5x CRON.TO's -0.15%. Michael Burry warns of potential big write-downs if synergy fails.
-1.38%
1.1-1.25x CRON.TO's -1.15%. Bill Ackman wonders if the firm invests more in intangible IP or capitalizes R&D aggressively.
-1.01%
Above 1.5x CRON.TO's -0.43%. Michael Burry sees potential overpaying or intangible bubble risk. Check synergy assumptions.
-10.68%
Below half of CRON.TO's 1942.77%. Michael Burry sees possible underinvestment in long-term assets. Verify capital constraints.
100.00%
Higher Tax Assets Growth compared to CRON.TO's zero value, indicating worse performance.
-50.22%
Above 1.5x CRON.TO's -8.77%. Michael Burry warns of potential hidden liabilities or intangible bloat.
0.20%
Below half of CRON.TO's 3.25%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
3.70%
≥ 1.5x CRON.TO's 0.45%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
16.13%
Less than half of CRON.TO's 37.77%. David Dodd sees a more disciplined AP approach or lower volume.
52.83%
Higher Short-Term Debt Growth compared to CRON.TO's zero value, indicating worse performance.
31.04%
Higher Tax Payables Growth compared to CRON.TO's zero value, indicating worse performance.
-1.71%
Both CRON.TO and the company show zero Deferred Revenue (Current) Growth.
No Data
No Data available this quarter, please select a different quarter.
15.82%
Less than half of CRON.TO's -39.24%. David Dodd sees a more disciplined short-term liability approach.
-5.81%
Higher Long-Term Debt Growth compared to CRON.TO's zero value, indicating worse performance.
-7210156610258723.00%
Both CRON.TO and the company show zero Non-Current Deferred Revenue Growth.
4.01%
Higher Deferred Tax Liabilities (Non-Current) Growth compared to CRON.TO's zero value, indicating worse performance.
1859068900.00%
Less than half of CRON.TO's -5.22%. David Dodd notes more conservative expansions in non-current obligations.
-4.44%
Similar yoy to CRON.TO's -4.21%. Walter Schloss sees parallel expansions in long-term liabilities.
No Data
No Data available this quarter, please select a different quarter.
-0.23%
Less than half of CRON.TO's -37.53%. David Dodd sees far fewer liability expansions relative to competitor.
5.23%
Above 1.5x CRON.TO's 0.24%. Michael Burry suspects heavy new equity expansion or dilution.
33.47%
≥ 1.5x CRON.TO's 6.24%. David Dodd sees higher yoy retained profits than competitor.
-33.57%
Less than half of CRON.TO's 76.98%. David Dodd sees fewer intangible or market-driven swings than competitor.
-3727.08%
Higher Other Stockholders' Equity Items Growth compared to CRON.TO's zero value, indicating worse performance.
5.49%
0.75-0.9x CRON.TO's 6.13%. Bill Ackman wonders if competitor is growing equity faster.
3.70%
≥ 1.5x CRON.TO's 0.45%. David Dodd sees faster overall balance sheet growth than competitor.
-10.68%
Below half CRON.TO's 3.45%. Michael Burry suspects major underinvestment or forced divestment.
-4.80%
Above 1.5x CRON.TO's -2.74%. Michael Burry sees a major jump. Investigate leverage rationale.
-481.95%
Less than half of CRON.TO's 1.05%. David Dodd sees better deleveraging or stronger cash buildup than competitor.
